Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Fundus Fluorescein Angiography on Semiautomated Aqueous Flare Measurements.
Halim MS, Onghanseng N, Park JH, Yilmaz M, Segawa A, Ertop M, Hassan M, Tran AN, Aktas Z, Ozdek S, Gurelik G, Do DV, Sepah YJ, Nguyen QD, Hasanreisoglu M. Halim MS, et al. Among authors: nguyen qd. Ocul Immunol Inflamm. 2022 Feb 17;30(2):424-427. doi: 10.1080/09273948.2020.1799036. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32966150 Free PMC article.
Brolucizumab-foreseeable workflow in the current scenario.
Sharma A, Kumar N, Parachuri N, Kuppermann BD, Bandello F, Regillo CD, Boyer D, Nguyen QD. Sharma A, et al. Among authors: nguyen qd. Eye (Lond). 2021 Jun;35(6):1548-1550. doi: 10.1038/s41433-020-01324-w. Epub 2021 Feb 2. Eye (Lond). 2021. PMID: 33531697 Free PMC article. No abstract available.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Reply.
Matsumiya W, Karaca I, Pham BH, Akhavanrezayat A, Uludag G, Yasar C, Ghoraba H, Mobasserian A, Regenold J, Halim MS, Sepah YJ, Do DV, Chong V, Nguyen QD. Matsumiya W, et al. Among authors: nguyen qd. Retina. 2024 Aug 1;44(8):e53-e55. doi: 10.1097/IAE.0000000000004134. Retina. 2024. PMID: 39047135
702 results